Correlation Between Mirati Ther and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Mirati Ther and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mirati Ther and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mirati Ther and Terns Pharmaceuticals, you can compare the effects of market volatilities on Mirati Ther and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mirati Ther with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mirati Ther and Terns Pharmaceuticals.
Diversification Opportunities for Mirati Ther and Terns Pharmaceuticals
0.83 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Mirati and Terns is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Mirati Ther and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Mirati Ther is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mirati Ther are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Mirati Ther i.e., Mirati Ther and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Mirati Ther and Terns Pharmaceuticals
If you would invest 3,132 in Mirati Ther on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Mirati Ther or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 4.76% |
Values | Daily Returns |
Mirati Ther vs. Terns Pharmaceuticals
Performance |
Timeline |
Mirati Ther |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Terns Pharmaceuticals |
Mirati Ther and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mirati Ther and Terns Pharmaceuticals
The main advantage of trading using opposite Mirati Ther and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mirati Ther position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.Mirati Ther vs. Sarepta Therapeutics | Mirati Ther vs. Krystal Biotech | Mirati Ther vs. Day One Biopharmaceuticals | Mirati Ther vs. Amylyx Pharmaceuticals |
Terns Pharmaceuticals vs. Capricor Therapeutics | Terns Pharmaceuticals vs. Soleno Therapeutics | Terns Pharmaceuticals vs. Bio Path Holdings | Terns Pharmaceuticals vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum |